MOG and multiple sclerosis: The peptide segment corresponding to residues 35–55 (MEVGWYRSPFSRVVHLYRNGK) of myelin oligodendrocyte glycoprotein (MOG) was considered as a potential peptide vaccine for multiple sclerosis.